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Introduction
Despite improved anaesthesia management guidelines peri-operative adverse respiratory events remain a major cause of morbidity and mortality during paediatric anaesthesia, with over three quarters of critical incidents and a third of all cardiac arrests being due to adverse respiratory events [1, 2] . Currently, children who are at risk of peri-operative adverse respiratory events are identified from a thorough medical and family history. In 2010, we performed an observational study that included more than 9000 children and identified risk factors for peri-operative adverse respiratory events [3] . Of the risk factors identified, a number are associated with increased airway inflammation, and include asthma, allergies or recent respiratory symptoms. However, a limitation of this approach is the inability to quantify the exact nature of risk factors and a reliance on the validity of the information obtained from the child or parent [4, 5] .
Improving the identification of children at risk of adverse respiratory events during the preanaesthetic assessment may reduce their incidence by allowing the anaesthetist to make a risk/benefit analysis regarding the optimal timing of surgery, as well as guiding the appropriate anaesthetic management of 'at risk' children. Such an individualized anaesthetic plan would also enhance medical management and improve outcome for these children.
Currently, the presence or absence of clinically relevant risk factors, including those linked to airway inflammation, are used to screen for the possibility of adverse respiratory events rather than any objective quantification of airway inflammation. Exhaled nitric oxide, a noninvasive, easily measurable, endogenous biomarker and surrogate for eosinophilic inflammation in the lungs, might be the substance that significantly improves our ability to predict the risk of adverse respiratory events in children undergoing surgery [6] [7] [8] [9] . Indeed, the development of portable eNO technology has enabled point-of-care measurement and has the potential to provide clinicians with an instantaneous and objective indication of airway inflammation [10, 11] .
The aim of this study was to test the utility of exhaled nitric oxide to improve the identification of children at increased risk of developing an adverse respiratory event when compared with obtaining a medical history alone. We hypothesized that the combination of a positive medical history together with elevated exhaled nitric oxide levels would improve the ability to identify children at risk of adverse respiratory events during anaesthesia.
Methods
The study was approved by the local research ethics committees and written informed consent was obtained from all the parents, as well as assent from the child where appropriate. Un-premedicated children aged 4 to 17 years undergoing elective minor surgery, with laryngeal mask insertion for airway management, were eligible for inclusion in the study. Inclusion criteria were children who, according their parent or carer, had no risk factors for any of the adverse respiratory events listed in table 1 [3] or if the parents reported two or more risk factors. Exclusion criteria were children with neurological disability, airway malformations, cardiac disease or those children in whom we could not perform expired nitric oxide (eNO) measurements. The eNO concentration was measured (Niox Mino: Aerocrine, Sweden) during a prolonged exhalation at a constant flow of 50 mL.s -1 as recommended by international guidelines [12] [13] [14] . This was performed at the preanaesthetic assessment on the day of surgery. Intravenous or inhalational induction of anaesthesia was performed as deemed appropriate by the attending anaesthetist using either propofol or sevoflurane respectively. Anaesthesia was maintained with sevoflurane in a 50:50 oxygen:air mixture for all patients. Following the procedure patients were transported in the left lateral position to the recovery room. Oxygen saturation levels were continuously monitored until the patient was discharged from the recovery area. Any adverse respiratory events in the peri-operative period were recorded i.e. at induction of anaesthesia, during maintenance and emergence from anaesthesia and throughout the recovery period until discharge to the ward [3] .
We aimed to determine the usefulness of eNO in predicting those children at high risk for adverse respiratory events. The study size of 100 control children with no risk factors and 180 children at high risk for adverse respiratory events (≥2 risk factors) was estimated to provide power of > 90% at a significance level of 0.05 to detect whether eNO is a good predictor for adverse respiratory events in the paediatric population [3] . The exhaled nitric oxide concentrations were categorized as normal or high as defined by the reference data of Malmberg et al [15] . Differences in concentrations of eNO and incidence of adverse respiratory events between the two groups were assessed using Pearson's Chi-square and Fischer's exact test. The predictive capacity of eNO, risk factors and the combination of eNO and risk factors was determined using Receiver Operator Characteristic (ROC) curve analysis.
A minimum area under the curve (AUC) of 0.65 was considered to indicate a good predictor for adverse respiratory events. The sensitivity, specificity, positive predictive value and negative predictive value were derived for each predictor of adverse respiratory events and binary logistic regression was used to derive the ability of each outcome (eNO, risk factors and combination of the two) to predict the incidence of adverse respiratory events using odds ratios. Statistical analysis was performed using SPSS version 22 (IBM, International Business Machines Corp., New York, USA) software and a p value <0.05 was considered statistically significant.
Results
Two hundred and eighty patients (100 children without risk factors and 180 children with risk factors) participated in the study. The data from 4 patients without risk factors and 8 with risk factors were excluded from analysis due to use of a tracheal tube instead of a laryngeal mask. The final analysis included 268 children, 96 in the no risk factor group and 172 in the ≥2 risk factors group. Demographic data are shown in table 2.
The proportion of children with eNO above the upper limit of normal was significantly higher in the risk factor group ( The results derived from the ROC and logistic regression analyses are shown in Table 3 . The vs. 89.6%).
Discussion
We have assessed a pre-operative point-of-care non-invasive surrogate measurement of airway inflammation (eNO) for its ability to predict peri-operative adverse respiratory events. Our results show that, in children with no risk factors, exhaled nitric oxide is not a good predictor for the occurrence of peri-operative adverse respiratory events. In children who present with risk factors, although exhaled nitric oxide predicts the occurrence of perioperative adverse respiratory events, it only marginally improves the predictive capability compared with risk factors obtained from the child's personal or family history alone.
Therefore there is no additional clinical benefit from measuring exhaled nitric oxide compared with taking a careful medical history alone.
The combination of an elevated eNO level and the presence of risk factors did improve the predictive ability for adverse respiratory events with an increase in the positive predictive value (PPV) to 45.0% compared with 30.8% for risk factors alone, however the negative predictive value was unchanged (88.6% for the combined analysis compared with 89.6% for risk factors alone).
Ideally, a new measurement for introduction to routine clinical paediatric practice should be widely available, non-invasive, sensitive, accurate, quick and easy to perform and cost effective, providing significant advantages compared with existing clinical tools. Given the marginal improvements in positive predictive value provided by eNO measurements and the increased healthcare costs, including the training of personnel and consumable costs, the results of our study do not support a role for eNO measurement in the pre-operative assessment of children.
Our study has several limitations. Firstly, in order to maximize the likelihood of accurate eNO measurements, we only included children older than four years who were able to perform the exhalation correctly and we excluded younger children. The incidence of adverse respiratory events is inversely proportional to age [3, 16] and it is possible that exhaled nitric oxide levels may prove to be a more reliable quantitative tool in younger children. Further studies are required, although lack of co-operation from younger children may make a prospective study difficult. Secondly, our results may have been influenced by the predictive equation we chose to classify exhaled nitric oxide levels as normal or abnormal. We based this on Malmberg's predictive equation which used a Finnish population model that included height as the major confounder [15] . In an attempt to discover whether this introduced bias, we also analysed our results using Buchvald's reference work carried out as a multicentre study in three European and two US centres which stratified the threshold values of normal eNO in healthy subjects aged between 4 and 17 years old according to age [17] . We performed a parallel binary normal/abnormal classification of measured eNO and obtained similar results to our initial results. Both these studies provide predictive equations for exhaled nitric oxide levels in healthy populations but they did not seem to affect the results of our cohort. Thirdly, even though eNO levels increase in asthmatic patients or in response to an allergic trigger, it is only a surrogate marker for airway inflammation [9, 13, 18, 19] and it may be less accurate than direct immunological plasma markers. However, we recently showed that even immunological plasma markers such as eosinophil count, total and specific (D.pteronyssinus, cat epithelia and grass pollen) IgE were still less predictive for perioperative adverse respiratory events compared with an accurate history of risk factors obtained from the child or family [20] .
We conclude that, in children with no risk factors, exhaled nitric oxide is not a good predictor for the occurrence of peri-operative adverse respiratory events. In children with risk factors, although an elevated exhaled nitric oxide level predicts the occurrence of perioperative adverse respiratory events, it only marginally improves the predictive capability compared with risk factors obtained from the child's personal or family history alone. There is no additional clinical benefit from measuring exhaled nitric oxide levels compared with an accurate medical history. 
